Inactive Instrument
Tricida, Inc. Stock
Stocks
TCDA
US89610F1012
Biotechnology & Medical Research
OTC Markets Traded
| 1 day | -99.90% |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 75 | 2013-09-30 |
| Director/Board Member | - | 2023-01-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22-11-22 | Sell | Director | 131,879 | 0.2369% | ||
| 22-11-21 | OrbiMed Advisors Private Equity
| Sell | Company | 10,280,947 | 18.4680% | |
| 22-11-21 | OrbiMed Advisors Private Equity
| Sell | Company | 10,280,947 | 18.4680% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.90% | -99.92% | - | - | 580 | |
| +0.34% | +1.09% | -10.80% | -5.05% | 43.13B | |
| +1.60% | +2.76% | +310.78% | +558.69% | 34.65B | |
| +1.30% | +1.63% | +5.85% | +46.61% | 30.03B | |
| -1.67% | -7.63% | +6.19% | -22.87% | 28B | |
| -1.06% | -2.60% | +9.08% | +21.51% | 24.45B | |
| +0.92% | +4.20% | - | - | 14.34B | |
| -1.97% | -3.94% | +45.50% | +99.94% | 13.14B | |
| +1.54% | +0.16% | +6.65% | +8.89% | 12.53B | |
| +2.35% | +2.35% | +100.96% | +83.74% | 12.25B | |
| Average | -9.62% | +0.65% | +59.27% | +98.93% | 23.61B | |
| Weighted average by Cap. | +0.40% | +1.19% | +64.54% | +115.43% |
Employees
57
